Avidity Biosciences, Inc.
RNA
$71.45
-$0.13-0.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -116.98% | -122.22% | -68.14% | -69.18% | -53.55% |
| Total Depreciation and Amortization | 48.73% | 18.49% | 22.46% | 20.00% | 25.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 119.77% | 63.79% | 63.97% | 5.10% | 6.31% |
| Change in Net Operating Assets | -108.59% | -1,333.11% | -124.80% | -108.95% | -18.99% |
| Cash from Operations | -138.01% | -207.16% | -77.36% | -705.24% | -78.35% |
| Capital Expenditure | 58.22% | -529.57% | -310.16% | -353.77% | -84.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.16% | 168.83% | 605.59% | -216.09% | -1,473.21% |
| Cash from Investing | -21.87% | 167.48% | 580.01% | -225.73% | -1,432.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 148.31% | -99.16% | -99.22% | -56.97% | 856,060.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 148.31% | -99.16% | -99.50% | -56.97% | 856,060.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.69% | -109.63% | -88.01% | -251.18% | -201.28% |